Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan:9:e2200247.
doi: 10.1200/GO.22.00247.

Breast Cancer in the United Arab Emirates

Affiliations
Review

Breast Cancer in the United Arab Emirates

Humaid O Al-Shamsi et al. JCO Glob Oncol. 2023 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/go/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Humaid O. Al-Shamsi

Employment: VPS Healthcare

Leadership: VPS Healthcare

Honoraria: AstraZeneca/Merck, Roche, Astellas Pharma, Vitaris, Lilly, Ipsen, Novartis

Consulting or Advisory Role: Roche

Speakers' Bureau: Novartis

Research Funding: Merck

Travel, Accommodations, Expenses: Lilly

Aydah Al-Awadhi

Honoraria: Pfizer, MSD Oncology, Roche, AstraZeneca/Daiichi Sankyo, Merck, Novartis, Lilly

Consulting or Advisory Role: Lilly, AstraZeneca/Daiichi Sankyo, MSD, Roche, Novartis/Pfizer

Speakers' Bureau: Merck, Roche, MSD, Novartis, AstraZeneca/Daiichi Sankyo, Lilly, Pfizer

Travel, Accommodations, Expenses: Pfizer

Saeed Rafii

Honoraria: AstraZeneca/MedImmune, MSD, Amgen, Merck

Ibrahim Abu-Gheida

Employment: VPS HealthCare

Honoraria: AstraZeneca/Merck

Mohamed Omara

Consulting or Advisory Role: New bridge

Travel, Accommodations, Expenses: Pfizer

Abdul Rahman El Kinge

Honoraria: Roche, Pfizer, Bristol Myers Squibb, Merck Serono

Consulting or Advisory Role: Bristol Myers Squibb, Pfizer, MSD Oncology

Mudhasir Ahmad

Employment: Lifecare Hospital Mussafah, Fortis Hospital Noida, India

Stock and Other Ownership Interests: Burjeel Holdings

Honoraria: Dr Reddy's Laboratories, Abbott Biotherapeutics, Zydus Pharmaceuticals, Horizon CME, Glenmark, AstraZeneca, Intas, Pfizer India, Biocon, Converge Pharma India, Novartis, Torrent Pharmaceuticals India

Consulting or Advisory Role: Torrent Pharmaceuticals India, Esperer Nutrition India

Travel, Accommodations, Expenses: AstraZeneca UAE, Esperer Nutrition India

Ernest J.T. Luiten

Consulting or Advisory Role: MedTech Corp Medical Equipment, Agendia

Travel, Accommodations, Expenses: MedTech Corp Medical Equipment

No other potential conflicts of interest were reported.

Figures

FIG 1
FIG 1
Registered BC cases in the UAE over the past 4 decades. BC, breast cancer; NCR, National Cancer Registry; UAE, United Arab Emirates.
FIG 2
FIG 2
(A) Age group distribution of female BC cases in the UAE in 2017. (B) ASIR for female BC cases in the UAE in 2017. Reproduced with permission. ASIR, age-specific incidence rate; BC, breast cancer; UAE, United Arab Emirates.
FIG 3
FIG 3
Breast cancer journal publications from the United Arab Emirates (2001-2021) by study type.

Similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL, et al. : Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209-249, 2021 - PubMed
    1. Cancer Incidence in United Arab Emirates Annual Report of the UAE—National Cancer Registry. Dubai, United Arab Emirates, Ministry of Health & Prevention, 2017
    1. Al-Shamsi HO, Alrawi S: Breast cancer screening in the United Arab Emirates: Is it time to call for a screening at an earlier age? J Cancer Prev Curr Res 9:123-126, 2018
    1. Bendardaf R, Saheb Sharif-Askari F, Saheb Sharif-Askari N, et al. : Incidence and clinicopathological features of breast cancer in the Northern Emirates: Experience from Sharjah Breast Care Center. Int J Womens Health 12:893-899, 2020 - PMC - PubMed
    1. Najjar H, Easson A: Age at diagnosis of breast cancer in Arab nations. Int J Surg 8:448-452, 2010 - PubMed

Publication types